This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Disease Info Card
Spinobulbar Atrophy
Information about Spinobulbar Atrophy: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Spinobulbar Atrophy
Most recent studies have shown that Spinobulbar Atrophy shares some biological mechanisms with amyotrophic-lateral-sclerosis, ataxia, ataxia-spinocerebellar, atrophy, dentatorubral-pallidoluysian-atrophy, dystrophy, huntington-disease, motor-neuron-disease, muscular-atrophy, muscular-disorders-atrophic, myotonic-dystrophy, nerve-degeneration, nervousness, neurodegenerative-disorders, opca-menzel-type, primary-lateral-sclerosis, sclerosis, spinal-and-bulbar-muscular-atrophy-x-linked-1, spinal-muscular-atrophy, trinucleotide-repeat-expansion.
Among the many pathways, these few ones have gauged particular interests from scientists studying Spinobulbar Atrophy, and have been seen in publications frequently: Aging, Autophagy, Cell Death, Dna Methylation, Innervation, Localization, Methylation, Neuroprotection, Pathogenesis, Protein Folding, Proteolysis, Regulation Of Gene Expression, Rna Interference, Rna Processing, Spermatogenesis, Transport
Quite a number of genes have been found to play important roles in Spinobulbar Atrophy, such as AKR1B1, AR, AREG, ATN1, ATXN1, CASP3, COX5B, DNAJA1, FDXR, HDAC6, HSPA4, HTT, IGFALS, LY6E, NR3C1, SLC6A4, SOD1, SPAST. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.